Implications of the allosteric kinetics of cytochrome P450s
- 18 May 2004
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 9 (11) , 478-484
- https://doi.org/10.1016/s1359-6446(04)03072-7
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Enzyme Kinetics of Cytochrome P450-Mediated ReactionsCurrent Drug Metabolism, 2012
- Kinetic analysis for multiple substrate interaction at the active site of cytochrome P450Published by Elsevier ,2004
- Atypical Enzyme Kinetics: Their Effect on In Vitro-In Vivo Pharmacokinetic Predictions and Drug InteractionsCurrent Drug Metabolism, 2003
- Is There a Toxicological Advantage for Non-hyperbolic Kinetics in Cytochrome P450 Catalysis?Published by Elsevier ,2002
- Midazolam Oxidation by Cytochrome P450 3A4 and Active-Site Mutants: an Evaluation of Multiple Binding Sites and of the Metabolic Pathway That Leads to Enzyme InactivationMolecular Pharmacology, 2002
- Allosteric phenomena in cytochrome P450‐catalyzed monooxygenationsEuropean Journal of Biochemistry, 2001
- Heterotropic Cooperativity of Cytochrome P450 3A4 and Potential Drug-Drug InteractionsCurrent Drug Metabolism, 2001
- Evaluation of Atypical Cytochrome P450 Kinetics with Two-Substrate Models: Evidence That Multiple Substrates Can Simultaneously Bind to Cytochrome P450 Active SitesBiochemistry, 1998
- Enhanced Detoxication Due to Distributive Catalysis and Toxic Thresholds: A Kinetic AnalysisBiochemistry, 1997
- Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamilyBiochemical Pharmacology, 1994